| Linda S Simoneaux, RN | |
|
390 River St, Springfield, VT 05156-2226 | |
| (802) 886-4500 | |
| (802) 886-4520 |
| Full Name | Linda S Simoneaux |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 390 River St, Springfield, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922311570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 026-0068657 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Linda S Simoneaux, RN 390 River St, Springfield, VT 05156-2226 Ph: (802) 886-4500 | Linda S Simoneaux, RN 390 River St, Springfield, VT 05156-2226 Ph: (802) 886-4500 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
Investigators at St. Jude Children's Research Hospital have discovered previously unsuspected mutations that contribute to the formation of pediatric acute lymphoblastic leukemia (ALL), the most common cancer in children.
The Pan American Health Organization has just released a new publication on adolescent health and positive behavior change greatly enhances the knowledge base on this important public health issue. It presents the firstever systematic collection and reporting of the application of behavioral change theories and models specifically to adolescents.
Philips Healthcare, a global leader in the health technology market, has signed a non-exclusive patent license agreement with the U.S. Air Force Research Laboratory for a mobile software application that provides integrated, real-time patient monitoring.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
› Verified 9 days ago
Maureen Shattuck, RN,CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 River St, Springfield, VT 05156 Phone: 802-886-8988 Fax: 802-886-8909 | |
Rebecca L. Brown, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 390 River Street, Springfield, VT 05156 Phone: 802-886-4500 Fax: 802-886-4560 | |
Sue T Euphrat, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Lincoln St, Springfield, VT 05156 Phone: 802-886-4500 Fax: 802-886-4520 | |
Sylvia Ann Flint, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 390 River Street, Health Care And Rehabilitation Services Of Se Vt Inc, Springfield, VT 05156 Phone: 802-886-4567 Fax: 802-886-4520 | |
Jill A. King, BA RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Lincoln Street, Springfield, VT 05156 Phone: 802-885-7280 Fax: 802-885-2683 | |
Claire M Lewis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 390 River Street, Springfield, VT 05156 Phone: 802-886-4500 Fax: 802-886-4560 | |
Michael M O'sullivan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Lincoln St, Springfield, VT 05156 Phone: 802-885-7280 Fax: 802-885-2593 |